Krystal Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:KRYS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
04 Jun 26	SellUS$7,606,744	Krish Krishnan	Individual	24,680	US$312.23
04 Jun 26	SellUS$7,606,585	Suma Krishnan	Individual	24,680	US$311.65
04 Mar 26	SellUS$6,454,882	Krish Krishnan	Individual	24,517	US$266.56
04 Mar 26	SellUS$6,475,542	Suma Krishnan	Individual	24,593	US$266.42

Insider Trading Volume

Insider Buying: KRYS insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of KRYS?
Owner Type	Number of Shares	Ownership Percentage
State or Government	10,254	0.0319%
Private Companies	140,000	0.436%
Hedge Funds	2,888,888	9%
Individual Insiders	3,020,384	9.41%
Institutions	26,051,799	81.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 88.67% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.8%	FMR LLC	4,373,986	US$1.4b	0.56%	0.06%
13.4%	BlackRock, Inc.	3,940,441	US$1.3b	0.07%	0.01%
9.8%	Avoro Capital Advisors LLC	2,888,888	US$938.2m	0%	10.6%
4.98%	Suma Krishnan	1,468,155	US$476.8m	-1.67%	no data
4.94%	Vanguard Portfolio Management, LLC	1,456,727	US$473.1m	0%	0.02%
4.92%	Krish Krishnan	1,450,253	US$471.0m	-1.69%	no data
4.46%	State Street Global Advisors, Inc.	1,314,434	US$426.9m	-2.08%	0.01%
3.95%	Vanguard Capital Management, LLC	1,165,324	US$378.4m	0%	0.01%
3.91%	Soleus Capital Management, L.P.	1,153,087	US$374.5m	22.5%	13.01%
2.8%	Capital Research and Management Company	824,720	US$267.8m	1.88%	0.01%
2.28%	Redmile Group, LLC	673,505	US$218.7m	-0.62%	12.88%
2.18%	Geode Capital Management, LLC	643,975	US$209.1m	5.25%	0.01%
2.1%	Hood River Capital Management LLC	619,586	US$201.2m	1.02%	1.53%
1.65%	T. Rowe Price Group, Inc.	485,074	US$157.5m	-8.47%	0.01%
1.63%	Bellevue Asset Management AG	481,785	US$156.5m	17.4%	2.99%
1.63%	Frazier Life Sciences Management, LP	481,307	US$156.3m	-1.46%	3.91%
1.59%	Dimensional Fund Advisors LP	468,990	US$152.3m	-4.86%	0.02%
1.43%	William Blair Investment Management, LLC	420,111	US$136.4m	7.72%	0.17%
1.19%	First Trust Advisors LP	350,521	US$113.8m	42.9%	0.06%
0.97%	Norges Bank Investment Management	284,573	US$92.4m	0%	0.01%
0.9%	Janus Henderson Group plc	266,659	US$86.6m	21.5%	0.03%
0.86%	Northern Trust Global Investments	252,463	US$82.0m	2.03%	0.01%
0.82%	Charles Schwab Investment Management, Inc.	241,991	US$78.6m	-0.32%	0.01%
0.78%	Invesco Capital Management LLC	230,972	US$75.0m	484%	0.02%
0.69%	Bank of America Corporation	203,125	US$66.0m	44.7%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/16 15:27
End of Day Share Price	2026/06/16 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Krystal Biotech, Inc. is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Caroline Palomeque	Berenberg
Alec Stranahan	BofA Global Research
Justin Zelin	B. Riley Securities, Inc.